Home Response Biomedical

Response Biomedical

In operation
IPO Delisting
Rapid Diagnostic Product R&D, Production, and Sales
Basic
Enterprise Profile

Basic Information

Response Biomedical focuses on providing diagnostic tools to help diagnose life-threatening diseases. The RAMP™ Reader developed by Response Biomedical can be used for multiple point-of-care diagnostic tests. Among them, the RAMP™ Reader Anthrax Test is the world's only reliable on-site detection system capable of accurately distinguishing the components of anthrax that may cause infection.
Response Biomedical Corp.
Vancouver,BritishColumbia,Canada
51~100 people
January 01, 1992
customersupport@responsebio.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing Independent Medical Laboratory Retail of Medical Supplies and Equipment
Technology
POCT
Concept
Infectious Diseases Department Cardiovascular Disease Infectious Diseases Laboratory Diagnosis
Application Scenarios
Novel Coronavirus Medical Devices Medical Device Consumables